Evidence map›Paper›PMID 34079517›Full record

ArticleFrontiers in endocrinology2021

Effect of Endometrium Thickness on Clinical Outcomes in Luteal Phase Short-Acting GnRH-a Long Protocol and GnRH-Ant Protocol.

Jie Zhang, Yi-Fei Sun, Yue-Ming Xu, Bao-Jun Shi, Yan Han, Zhuo-Ye Luo, Zhi-Ming Zhao, Gui-Min Hao, Bu-Lang Gao

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Impact of endometrial thickness on reproductive outcome in fresh and frozen-thawed embryo transfer: systematic review and meta-analysis.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2025
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jie ZhangDepartment of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Yi-Fei SunDepartment of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Yue-Ming XuDepartment of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Bao-Jun ShiDepartment of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Yan HanDepartment of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Zhuo-Ye LuoDepartment of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Zhi-Ming ZhaoDepartment of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Gui-Min HaoDepartment of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Bu-Lang GaoDepartment of Reproductive Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the factors that influence luteal phase short-acting gonadotropin-releasing hormone agonist (GnRH-a) long protocol and GnRH-antagonist (GnRH-ant) protocol on pregnancy outcome and quantify the influence. About the statistical analysis, it is not correct for the number of gravidities. Methods: Infertile patients (n = 4,631) with fresh Results: The GnRH-ant and the GnRH-a long protocols had comparable clinical outcomes in the clinical pregnancy, live birth, and miscarriage rate after propensity score matching. In the medium endometrial thickness of 7-10 mm, the clinical pregnancy rate (61.81 Conclusions: The GnRH-ant protocol has better clinical pregnancy outcomes when the endometrial thickness is in the medium thickness range of 7-10 mm. The optimal threshold interval for better clinical pregnancy outcomes of the GnRH-ant protocol is significantly narrower than that of the GnRH-a protocol. When the endometrial thickness exceeds 12 mm, the clinical pregnancy rate and live birth rate of the GnRH-ant protocol show a significant downward trend, probably indicating some negative effects of GnRH-ant on the endometrial receptivity to cause a decrease of the clinical pregnancy rate and live birth rate if the endometrial thickness exceeds 12 mm.

Indexed as

AdultBirth RateChinaEndometriumFemaleFertility Agents, FemaleFertilization in VitroGonadotropin-Releasing HormoneHormone AntagonistsHumansInfant, NewbornInfertilityLuteal PhaseOrgan SizeOvulation InductionPregnancyFertility Agents, FemaleGonadotropin-Releasing HormoneHormone Antagonistsclinical pregnancyendometrial thicknessgonadotropin-releasing hormone agonistgonadotropin releasing hormone antagonistpregnancy outcome

Identifiers

PMID34079517
PMCPMC8165441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.